实用癌症杂志
實用癌癥雜誌
실용암증잡지
THE PRACTICAL JOURNAL OF CANCER
2014年
6期
654-656
,共3页
谢晓阳%李季%易军%高健
謝曉暘%李季%易軍%高健
사효양%리계%역군%고건
低分子肝素%食管癌%血栓性疾病
低分子肝素%食管癌%血栓性疾病
저분자간소%식관암%혈전성질병
Low molecular weight heparin%Esophageal tumor%Thrombotic disease
目的:探讨低分子肝素对食管癌患者术后血栓性疾病发生的影响。方法将360例行食管癌手术的患者随机分为观察组与对照组,每组180例。观察组于术后第1天皮下注射低分子肝素4000~6150 IU或低分子肝素钠4000~6000 IU,每天1次,连用5 d。对照组给予常规方法进行治疗。术前及术后5天测定患者的血小板( PLT)、活化部分凝血活酶时间( APTT)、纤维蛋白原( Fib)、D-二聚体( D-D)及凝血酶原时间( PT)。观察2组食管癌手术后的胸腔积液引流量。结果手术前2组食管癌患者PT明显缩短,D-D及Fib均明显高于正常范围,手术后第1天2组食管癌患者的PT明显缩短,D-D较术前明显升高(P<0.05)。观察组术后第2天PT达到最低水平,D-D及Fib达到最高水平。术后第5天观察组PT较术前及术后第1天延长,D-D及Fib明显降低。观察组与对照组相比,Fib、PT在术后2~5天及D-二聚体在术后1~5天的差异均有统计学意义(P<0.05)。食管癌手术后观察组的平均胸腔积液引流量为(527.9±132.5)ml,对照组的平均积液引流量为(531.6±121.4)ml,2组差异无统计学意义(χ2=0.385,P>0.05)。结论经预防性的给予低分子肝素进行治疗后,可以明显降低食管癌患者术后血栓性疾病的发生率。
目的:探討低分子肝素對食管癌患者術後血栓性疾病髮生的影響。方法將360例行食管癌手術的患者隨機分為觀察組與對照組,每組180例。觀察組于術後第1天皮下註射低分子肝素4000~6150 IU或低分子肝素鈉4000~6000 IU,每天1次,連用5 d。對照組給予常規方法進行治療。術前及術後5天測定患者的血小闆( PLT)、活化部分凝血活酶時間( APTT)、纖維蛋白原( Fib)、D-二聚體( D-D)及凝血酶原時間( PT)。觀察2組食管癌手術後的胸腔積液引流量。結果手術前2組食管癌患者PT明顯縮短,D-D及Fib均明顯高于正常範圍,手術後第1天2組食管癌患者的PT明顯縮短,D-D較術前明顯升高(P<0.05)。觀察組術後第2天PT達到最低水平,D-D及Fib達到最高水平。術後第5天觀察組PT較術前及術後第1天延長,D-D及Fib明顯降低。觀察組與對照組相比,Fib、PT在術後2~5天及D-二聚體在術後1~5天的差異均有統計學意義(P<0.05)。食管癌手術後觀察組的平均胸腔積液引流量為(527.9±132.5)ml,對照組的平均積液引流量為(531.6±121.4)ml,2組差異無統計學意義(χ2=0.385,P>0.05)。結論經預防性的給予低分子肝素進行治療後,可以明顯降低食管癌患者術後血栓性疾病的髮生率。
목적:탐토저분자간소대식관암환자술후혈전성질병발생적영향。방법장360례행식관암수술적환자수궤분위관찰조여대조조,매조180례。관찰조우술후제1천피하주사저분자간소4000~6150 IU혹저분자간소납4000~6000 IU,매천1차,련용5 d。대조조급여상규방법진행치료。술전급술후5천측정환자적혈소판( PLT)、활화부분응혈활매시간( APTT)、섬유단백원( Fib)、D-이취체( D-D)급응혈매원시간( PT)。관찰2조식관암수술후적흉강적액인류량。결과수술전2조식관암환자PT명현축단,D-D급Fib균명현고우정상범위,수술후제1천2조식관암환자적PT명현축단,D-D교술전명현승고(P<0.05)。관찰조술후제2천PT체도최저수평,D-D급Fib체도최고수평。술후제5천관찰조PT교술전급술후제1천연장,D-D급Fib명현강저。관찰조여대조조상비,Fib、PT재술후2~5천급D-이취체재술후1~5천적차이균유통계학의의(P<0.05)。식관암수술후관찰조적평균흉강적액인류량위(527.9±132.5)ml,대조조적평균적액인류량위(531.6±121.4)ml,2조차이무통계학의의(χ2=0.385,P>0.05)。결론경예방성적급여저분자간소진행치료후,가이명현강저식관암환자술후혈전성질병적발생솔。
Objective To explore the effect of low molecular weight heparin on thrombotic disease in postoperative e -sophageal carcinoma .Methods 360 cases of esophageal cancer were randomly divided into the observation group and the control group ( n =180 ) .The observation group received subcutaneous low molecular weight heparin or subcutaneous low molecular weight heparin sodium 4 000~6 000 IU daily from the 1st of surgery for 5 days,and the control group received conventional treat-ment.PLT,APTT,Fib,D-D and PT of the 2 groups were detected .Pleural effusion drainage of the 2 groups were compared .Re-sults Before surgery ,PT was shorter than normal range ,but Fib and D-D were higher .First day after surgery ,PT decreased sig-nificantly,while D-D increased than before surgery (P<0.05).On the 2nd day,the PT reached the lowest level ,but the Fib and D-D reached the highest level .On the 5th day,the PT of the observation group extended while Fib and D-D decreased significant-ly.Fib and PT in 2~5 days and D-D in 1~5 days of the 2 groups had statistical significance (P<0.05).The postoperative aver-age pleural effusion drainage of the observation group and the control group were (527.9 ±132.5) ml and (531.6 ±121.4) ml, there had no statistical difference (χ2 =0.385,P>0.05).Conclusion Preventive low molecular weight heparin treatment can significantly reduce the incidence of thrombotic diseases .